Boulay, Gaylor Broye, Liliane Dong, Rui Iyer, Sowmya Sanalkumar, Rajendran Xing, Yu-Hang Buisson, Rémi Rengarajan, Shruthi Naigles, Beverly Duc, Benoît
...
EWS fusion oncoproteins underlie several human malignancies including Desmoplastic Small Round Cell Tumor (DSRCT), an aggressive cancer driven by EWS-WT1 fusion proteins. Here we combine chromatin occupancy and 3D profiles to identify EWS-WT1-dependent gene regulation networks and target genes. We show that EWS-WT1 is a powerful chromatin activator...
Morales, Ayana E Gumenick, Ruby Genovese, Caitlyn M Jang, Yun Yeong Ouedraogo, Ariene de Garayo, Maite Ibáñez Pannellini, Tania Patel, Sanjay Bott, Matthew E Alvarez, Julio
...
In people living with HIV, Kaposi Sarcoma (KS), a vascular neoplasm caused by KS herpesvirus (KSHV/HHV-8), remains one of the most common malignancies worldwide. Individuals living with HIV, receiving otherwise effective antiretroviral therapy, may present with extensive disease requiring chemotherapy. Hence, new therapeutic approaches are needed. ...
Fu, Siqing Piccioni, David E Liu, Hongtao Lukas, Rimas V Kesari, Santosh Aregawi, Dawit Hong, David S Yamaguchi, Kenichiro Whicher, Kate Zhang, Yi
...
WT2725 is a Wilms' tumor gene 1 (WT1)-derived-oligopeptide vaccine designed to induce WT1-specific cytotoxic T-lymphocytes against WT1+ tumors in human leukocyte antigen (HLA)-A*0201+ and/or HLA-A*0206+ patients. Here, we report the results of a phase I study of WT2725. In this phase I, open-label, dose-escalation and expansion two-part study, the ...
Chow, Warren A Yee, Jiing-Kuan Tsark, Walter Wu, Xiwei Qin, Hanjun Guan, Min Ross, Jeffrey S Ali, Siraj M Millis, Sherri Z
BackgroundDesmoplastic small round cell tumor (DSRCT) is a rare, highly aggressive, translocation-associated soft-tissue sarcoma that primarily affects children, adolescents, and young adults, with a striking male predominance. It is characterized by t(11;22) generating a novel EWSR1-WT1 fusion gene. Secondary genomic alterations are rarely describ...
Jacobsohn, David A Loken, Michael R Fei, Mingwei Adams, Alexia Brodersen, Lisa Eidenschink Logan, Brent R Ahn, Kwang Woo Shaw, Bronwen E Kletzel, Morris Olszewski, Marie
...
We enrolled 150 patients in a prospective multicenter study of children with acute myeloid leukemia undergoing hematopoietic stem cell transplantation (HSCT) to compare the detection of measurable residual disease (MRD) by a "difference from normal" flow cytometry (ΔN) approach with assessment of Wilms tumor 1 (WT1) gene expression without access t...
Ueda, N. Uemura, Y. Zhang, R. Kitayama, S. Iriguchi, S. Kawai, Y. Yasui, Y. Tatsumi, M. Ueda, T. Liu, T.-Y.
...
peer reviewed / CD4+ T helper (Th) cell activation is essential for inducing cytotoxic T lymphocyte (CTL) responses against malignancy. We reprogrammed a Th clone specific for chronic myelogenous leukemia (CML)-derived b3a2 peptide to pluripotency and re-differentiated the cells into original TCR-expressing T-lineage cells (iPS-T cells) with gene e...
Rungrojsakul, Methee Katekunlaphan, Trinnakorn Saiai, Aroonchai Ampasavate, Chadarat Okonogi, Siriporn Sweeney, Colleen A Anuchapreeda, Songyot
BackgroundWilms' tumor 1 (WT1) is a biological marker for predicting leukemia progression. In this study, mammea E/BB, an active compound from Saraphi (Mammea siamensis) seed extract was examined for its effect on down-regulatory mechanism of WT1 gene expression, WT1 protein and mRNA stability, and cell proliferation in K562 cell line.MethodsM. sia...
Wang, Huan‐You McMahon, Caitlin Ali, Siraj M Young, Lauren E Yekezare, Somaye Ross, Jeffrey S Ball, Edward D
Jorgenson, Eric Makki, Nadja Shen, Ling Chen, David C Tian, Chao Eckalbar, Walter L Hinds, David Ahituv, Nadav Avins, Andrew
Inguinal hernia repair is one of the most commonly performed operations in the world, yet little is known about the genetic mechanisms that predispose individuals to develop inguinal hernias. We perform a genome-wide association analysis of surgically confirmed inguinal hernias in 72,805 subjects (5,295 cases and 67,510 controls) and confirm top as...
IWABUCHI, MINAMI NARITA, MIWAKO UCHIYAMA, TAKAYOSHI IWAYA, SHUNPEI OIWA, ERI NISHIZAWA, YOSHINORI HASHIMOTO, SHIGEO BONEHILL, AUDE KASAHARA, NORIYUKI TAKIZAWA, JUN
...
The aim of the present study was to enhance the efficiency of leukemia immunotherapy by increasing the antigen-specific cytotoxic T lymphocyte-inducing ability of leukemia cells. The leukemic plasmacytoid dendritic cell line PMDC05 containing the HLA-A02/24 antigen, which was previously established in our laboratory (Laboratory of Hematology and On...